A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

Nurses and advanced practice registered nurses (APRNs) play a central role in preventive care, screening, chronic disease management, and patient education. Expanding this workforce is particularly ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Study finds similar safety regardless of anticoagulant type.In a study of adults with advanced prostate cancer taking androgen-receptor pathway ...

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, experts have said. The treatment ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

CCT400028 has been recognised as a high-quality chemical probe and is recommended by the Chemical Probes Portal as a leading Aurora A degrader for laboratory use. The molecule provides researchers ...

A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...

Click here for a copy of the latest data. New data has revealed a 25% increase in the number of deaths from prostate cancer in Australia since 2007 ...

aDepartment of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, NSW, Australia bDepartment of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia ...

What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led pathways? As an early trainee in urology, I used to learn about transrectal ...